| Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non‐small cell lung cancer T Takenaka, I Yoshino, H Kouso, T Ohba, T Yohena, A Osoegawa, F Shoji, ... International journal of cancer 121 (4), 895-900, 2007 | 168 | 2007 |
| Surgical treatment of neurogenic tumors of the chest M Yamaguchi, I Yoshino, S Fukuyama, A Osoegawa, T Kameyama, ... Annals of thoracic and cardiovascular surgery 10 (3), 148-151, 2004 | 120 | 2004 |
| Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer A Osoegawa, I Yoshino, S Tanaka, K Sugio, T Kameyama, M Yamaguchi, ... Journal of clinical oncology 22 (20), 4165-4173, 2004 | 106 | 2004 |
| Plasma D-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer M Yamamoto, K Yoshinaga, A Matsuyama, T Iwasa, A Osoegawa, ... Oncology 83 (1), 10-15, 2012 | 93 | 2012 |
| Induction of epithelial‐mesenchymal transition‐related genes by benzo [a] pyrene in lung cancer cells I Yoshino, T Kometani, F Shoji, A Osoegawa, T Ohba, H Kouso, ... Cancer 110 (2), 369-374, 2007 | 91 | 2007 |
| Serum markers associated with treatment response and survival in non-small cell lung cancer patients treated with anti-PD-1 therapy K Takada, S Takamori, Y Yoneshima, K Tanaka, I Okamoto, ... Lung Cancer 145, 18-26, 2020 | 64 | 2020 |
| The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer H Takeuchi, M Abe, Y Takumi, T Hashimoto, R Kobayashi, A Osoegawa, ... PloS one 12 (12), e0189166, 2017 | 64 | 2017 |
| Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors K Takada, Y Yoneshima, K Tanaka, I Okamoto, M Shimokawa, S Wakasu, ... Journal of Cancer Research and Clinical Oncology 146, 1217-1225, 2020 | 45 | 2020 |
| 18F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer K Takada, G Toyokawa, Y Yoneshima, K Tanaka, I Okamoto, ... Scientific reports 9 (1), 13362, 2019 | 45 | 2019 |
| Overexpression of Jun activation domain‐binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features A Osoegawa, I Yoshino, T Kometani, M Yamaguchi, T Kameyama, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 42 | 2006 |
| Thoracoscopic surgery combined with a supraclavicular approach for removing a cervico-mediastinal neurogenic tumor: a case report M Yamaguchi, I Yoshino, T Kameyama, A Osoegawa, T Tagawa, ... Annals of thoracic and cardiovascular surgery 12 (3), 194, 2006 | 36 | 2006 |
| Expression of mismatch repair proteins, hMLH1/hMSH2, in non‐small cell lung cancer tissues and its clinical significance H Kouso, I Yoshino, N Miura, T Takenaka, T Ohba, T Yohena, ... Journal of Surgical Oncology 98 (5), 377-383, 2008 | 32 | 2008 |
| Mutations of the EGFR, K-ras, EML4–ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma T Ohba, G Toyokawa, A Osoegawa, F Hirai, M Yamaguchi, K Taguchi, ... Surgery today 46, 1091-1098, 2016 | 30 | 2016 |
| Interleukin-38 promotes tumor growth through regulation of CD8+ tumor-infiltrating lymphocytes in lung cancer tumor microenvironment F Kinoshita, T Tagawa, T Akamine, K Takada, Y Yamada, Y Oku, K Kosai, ... Cancer Immunology, Immunotherapy 70, 123-135, 2021 | 29 | 2021 |
| Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy K Takada, K Kohashi, M Shimokawa, A Haro, A Osoegawa, T Tagawa, ... Lung Cancer 128, 26-32, 2019 | 28 | 2019 |
| LKB1 Mutations Frequently Detected in Mucinous Bronchioloalveolar Carcinoma A Osoegawa, T Kometani, K Nosaki, K Ondo, M Hamatake, F Hirai, T Seto, ... Japanese journal of clinical oncology 41 (9), 1132-1137, 2011 | 26 | 2011 |
| A clinicopathological and prognostic analysis of PD-L2 expression in surgically resected primary lung squamous cell carcinoma T Matsubara, K Takada, K Azuma, S Takamori, G Toyokawa, A Haro, ... Annals of surgical oncology 26, 1925-1933, 2019 | 24 | 2019 |
| Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib A Osoegawa, JJ Gills, S Kawabata, PA Dennis Oncotarget 8 (50), 87044, 2017 | 24 | 2017 |
| Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma I Yoshino, A Osoegawa, T Yohena, T Kameyama, E Oki, S Oda, ... Respiratory medicine 99 (3), 308-312, 2005 | 24 | 2005 |
| Inflammatory myofibroblastic tumor of the mediastinum presenting as superior vena cava syndrome M Yamaguchi, I Yoshino, A Osoegawa, T Kameyama, T Tagawa, ... The Journal of Thoracic and Cardiovascular Surgery 126 (3), 870-872, 2003 | 24 | 2003 |
